Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Saunders

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
British Journal of Cancer|November 23, 2020
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.
The Journal of Pathology. Clinical Research|September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasetsAnja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 29, 2024
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumorsKathryn A F Pennel, Phimmada Hatthakarnkul, Colin S Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal CancerChristopher J M Williams, Faye Elliott, Nancy Sapanara, et al.
Nature Communications|May 16, 2019
Association analyses identify 31 new risk loci for colorectal cancer susceptibilityPhilip J Law, Maria Timofeeva, Ceres Fernandez-Rozadilla, et al.
The Bone & Joint Journal|December 2, 2024
The National Joint Registry Data Quality Audit of elbow arthroplastyZaid Hamoodi, Joanne Shapiro, Adrian Sayers, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
British Journal of Cancer|November 23, 2020
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursLaura Horsley, Jeff Cummings, Mark Middleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.
The Journal of Pathology. Clinical Research|September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasetsAnja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 29, 2024
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumorsKathryn A F Pennel, Phimmada Hatthakarnkul, Colin S Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal CancerChristopher J M Williams, Faye Elliott, Nancy Sapanara, et al.
Nature Communications|May 16, 2019
Association analyses identify 31 new risk loci for colorectal cancer susceptibilityPhilip J Law, Maria Timofeeva, Ceres Fernandez-Rozadilla, et al.
The Bone & Joint Journal|December 2, 2024
The National Joint Registry Data Quality Audit of elbow arthroplastyZaid Hamoodi, Joanne Shapiro, Adrian Sayers, et al.
Pageof 9